estimated revenue glp-1 drugs Agonists Weight Loss Market Report, 2025-2030 GLP-1 Receptor Agonist Market Size

GLP-1 agonist drugs, often called GLP-1s, are injectable medications that work by mimicking the GLP-1 hormone that your small intestine makes in response to food

November 6, 2025

This underscores why DermaVue's structured program includes a gradual tapering protocol and metabolic maintenance phase

Tirzepatides dual mechanism of action that may help maximize weight loss Chances are someone you know is taking a GLP-1 medication

What is the Precision Peptide Genetic Test, and how does it help me choose a medication

In recent years, the gut-brain axis has been increasingly considered a promising topic for the study of CNS-related diseases because the gut microbiota and gut hormones have been shown to interact with other organs including the brain (Knight et al., 2017), although the mechanisms involved in gut homeostasis and brain function are as yet uncharacterized (Neufeld and Foster, 2009)